Consolidated Portfolio Review Corp Stryker Corp Transaction History

Consolidated Portfolio Review Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$253.85 - $299.46 $8,630 - $10,181	34 Added 3.58%	983 $294 Million
Q3 2023 Nov 13, 2023	BUY	$266.54 - $302.43 $1,066 - $1,209	4 Added 0.42%	949 $259 Million
Q2 2023 Aug 14, 2023	BUY	$271.49 - $305.09 $13,574 - $15,254	50 Added 5.59%	945 $288 Million
Q1 2023 May 11, 2023	BUY	$246.13 - $285.47 $220,286 - $255,495	895 New	895 $255 Million

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Consolidated Portfolio Review Corp, based on Form 13F filings with the SEC.

Stay updated on Consolidated Portfolio Review Corp with notifications on news.